Healthcare -
Biotechnology - NASDAQ - US
$ 2.385
-5.36 %
$ 313 M
Market Cap
-1.45
P/E
Price Target
Average
570.86%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
27.34%
Net Income
Estimate
15.64%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Prime Medicine, Inc.
Wall Street analysts predict an average 1-year price target for PRME of $16 , with forecasts ranging from
a
low of
$12 to a high of $23 .
PRME Lowest Price Target
Wall Street Target
12 USD
403.14%
PRME Average Price Target
Wall Street Target
16 USD
570.86%
PRME Highest Price Target
Wall Street Target
23 USD
864.36%
REVENUE FORECAST
Revenue Forecast Chart PRME
EBIT FORECAST
EBIT Forecast Chart PRME
NET INCOME FORECAST
Net Income Chart PRME